Two studies support the safety and tolerability of Nuplazid (pimavanserin) in older or frail adults with psychosis associated with…
Steve Bryson, PhD
Steve holds a PhD in biochemistry from the Faculty of Medicine at the University of Toronto, Canada. As a medical scientist for 18 years, he worked in both academia and industry, where his research focused on the discovery of new medicines to treat inflammatory disorders and infectious diseases. Steve is a published author in multiple peer-reviewed scientific journals and a patented inventor.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Steve Bryson, PhD
Changes in the levels of thyroid hormones in the bloodstream are related to cognitive impairments in people with…
Nearly all people with Parkinson’s disease taking part in Medtronic‘s ADAPT-PD trial had symptom-related brain signals strong enough…
About 1 in 5 people with Parkinson’s disease in Italy have a family history of the disorder when the…
Scientists have discovered how to therapeutically target a class of molecular switches called GTPases that are involved in Parkinson’s…
Nearly 1 in 3 people in Japan with Parkinson’s disease also had sarcopenia, a progressive loss of muscle mass…
Levels of the trace metal selenium and its associated proteins, called selenoproteins, are altered in the blood of adults with…
Five top models for a wearable sensor that can monitor and measure freezing of gait (FOG) — a sudden inability…
Adaptive deep brain stimulation (DBS) outperformed traditional DBS in alleviating motor symptoms and enhancing the quality of life for…
A complex of proteins involved in cellular trafficking, called the BBSome, plays a role in regulating the transport of dopamine,…